TruBridge, Inc. (TBRG) Earnings Call Transcripts

27 earnings calls from February 2020 to March 31, 2026

NasdaqGS US Health Care Health Care Technology

TruBridge, Inc.'s Latest Earnings Call - Q4 FY2025

In the fourth quarter of fiscal year 2025, TruBridge, Inc. reported total revenue of $87.2 million, which was in line with the midpoint of revised guidance, and adjusted EBITDA of $19.2 million, representing a margin expansion to 22%. For the full year, revenue reached $346.8 million, a modest 1.4% increase year-over-year, while adjusted EBITDA grew 23% to $68.7 million. Management signaled a cautious outlook for 2026, expecting modest revenue growth and approximately 200 basis points of adjusted EBITDA margin improvement, but did not provide formal guidance due to an ongoing strategic review process.

Reported metrics

MetricValueContext
Q4 Revenue $87.2 million (inline) in line with midpoint of revised guidance
Full Year Revenue $346.8 million (inline) up 1.4% YoY
Q4 Adjusted EBITDA $19.2 million (positive) margin expanded to 22%
Full Year Adjusted EBITDA $68.7 million (positive) up 23% YoY
Bookings Q4 $19.8 million (positive) up from $15.5 million sequentially
Financial Health Revenue Q4 $56.2 million (positive) up 2% YoY

Guidance from management

Management expects modest revenue growth in 2026 and approximately 200 basis points of adjusted EBITDA margin improvement, but did not provide formal guidance due to the ongoing strategic review process.

What management said

No, I think you're on the right track. Like you said, the recurring revenues and some assumption of bookings conversion because, as you know, bookings have the same -- you can apply some formulaic view of how bookings translate into revenue and attrition. I think that's the right way of doing it.
— Vinay Bassi, Q4 FY2025 earnings call
I'm going to do my best to not be tongue in cheek here, Sean, but you kind of answered the question at the top, very limited. And what I would say is right now, we do not have a time line on this, to your point. I think the Board is being super thoughtful about this. And again, with the focus of shareholder value as the guiding light to the process and making sure that it's more about getting to the right outcome as ...
— Christopher Fowler, Q4 FY2025 earnings call

What analysts pressed on

Analysts expressed concerns about customer retention rates, particularly in the CBO segment, and the potential impact of regulatory changes on purchasing behavior. There were also inquiries about the visibility of bookings conversion and the timeline for the strategic review process.

Main topics on the call

Read the full TruBridge, Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

About TruBridge, Inc.

TruBridge, Inc. (TBRG) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 27 calls on record spanning February 11, 2020 to March 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 27 TruBridge, Inc. earnings call transcripts on record, spanning February 11, 2020 to March 31, 2026. Based on this history, TruBridge, Inc. reports quarterly. The most recent call on file is dated March 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
TBRG
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Health Care Technology
Calls on record
27
First call
February 11, 2020
Most recent
March 31, 2026
Reporting cadence
quarterly
Quarter Date
Q4 FY2025 Mar 31, 2026 Read transcript
Q3 FY2025 Nov 7, 2025 Read transcript
Q2 FY2025 Aug 8, 2025 Read transcript
Q1 FY2025 May 7, 2025 Read transcript
Q4 FY2024 Mar 10, 2025 Read transcript
Q3 FY2024 Nov 8, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Q1 FY2024 May 10, 2024 Read transcript
Q4 FY2023 Feb 29, 2024 Read transcript
Q3 FY2023 Nov 8, 2023 Read transcript
Q2 FY2023 Aug 9, 2023 Read transcript
Q1 FY2023 May 9, 2023 Read transcript
Q4 FY2022 Feb 14, 2023 Read transcript
Q3 FY2022 Nov 1, 2022 Read transcript
Q2 FY2022 Aug 2, 2022 Read transcript
Q1 FY2022 May 3, 2022 Read transcript
M&A Calls Mar 2, 2022 Read transcript
Q4 FY2021 Feb 15, 2022 Read transcript
Q3 FY2021 Nov 9, 2021 Read transcript
Q2 FY2021 Aug 3, 2021 Read transcript
M&A Calls May 13, 2021 Read transcript
Q1 FY2021 May 11, 2021 Read transcript
Q4 FY2020 Feb 9, 2021 Read transcript
Q3 FY2020 Nov 5, 2020 Read transcript
Q2 FY2020 Aug 4, 2020 Read transcript
Q1 FY2020 May 5, 2020 Read transcript
Q4 FY2019 Feb 11, 2020 Read transcript